Misal Singh, director-institutional research, Religare Capital Markets Ltd, believes that if one has a long enough view, one should look at buying the Crompton Greaves stock. With Q2 numbers disappointing, the stock sold off 9 per cent today. Misal thinks a lot of institutions are thinking of buying it, but no one has pulled the trigger yet.